 |
Top 64 Eye Disease and Blindness treatment startups
Oct 12, 2024 | By Jason Kwon | 22 |
These startups develop new technologies to improve vision and cure cataract, glaucoma, myopia, hyperopia, astigmatism, presbyopia, blindness.
1
Country: USA | Funding: $15M
Lumata Health is a practice management platform for ophthalmology
Lumata Health is a practice management platform for ophthalmology
2
Country: Israel | Funding: $126M
Orasis Pharmaceuticals develops a corrective eye drop to treat presbyopia as an alternative to reading glasses.
Orasis Pharmaceuticals develops a corrective eye drop to treat presbyopia as an alternative to reading glasses.
3
Country: USA | Funding: $54M
XP Health is an artificial intelligence-powered vision benefits platform for employees.
XP Health is an artificial intelligence-powered vision benefits platform for employees.
4
Country: Canada | Funding: CA$3.8M
For a half century, ophthalmic surgeons have envisioned an intraocular lens capable of restoring eyesight at all distances. Ocumetics Technology Corporation was founded to achieve this goal. Employing state-of-the art materials and production techniques, Ocumetics Technology Corporation is in the process of developing a highly advanced intraocular lens, one that is capable of restoring clear vision at all distances, without glasses or contact lenses, and without the visual quality problems that have plagued current accommodative and multifocal intraocular lens designs.
For a half century, ophthalmic surgeons have envisioned an intraocular lens capable of restoring eyesight at all distances. Ocumetics Technology Corporation was founded to achieve this goal. Employing state-of-the art materials and production techniques, Ocumetics Technology Corporation is in the process of developing a highly advanced intraocular lens, one that is capable of restoring clear vision at all distances, without glasses or contact lenses, and without the visual quality problems that have plagued current accommodative and multifocal intraocular lens designs.
5
Country: South Korea | Funding: $24.8M
Medi Whale offers medical AI software for eye disease detection. Its devices assess cardiovascular risk through the use of retinal imagery and artificial intelligence
Medi Whale offers medical AI software for eye disease detection. Its devices assess cardiovascular risk through the use of retinal imagery and artificial intelligence
6
Country: USA | Funding: $763.8M
Spark is a leader in the field of gene therapy, seeking to transform the lives of patients by developing potential one-time, life-altering treatments for debilitating genetic diseases. We initially are applying our integrated platform to treat rare diseases where no, or only palliative, therapies exist.
Spark is a leader in the field of gene therapy, seeking to transform the lives of patients by developing potential one-time, life-altering treatments for debilitating genetic diseases. We initially are applying our integrated platform to treat rare diseases where no, or only palliative, therapies exist.
7
Country: USA | Funding: $694.9M
Pliant Therapeutics is focused on discovering, developing and commercializing breakthrough treatments for fibrotic diseases.
Pliant Therapeutics is focused on discovering, developing and commercializing breakthrough treatments for fibrotic diseases.
8
Country: USA | Funding: $317.8M
Emendo Biotherapeutics develops gene editing platform to expand the list of diseases amenable to treatment with gene editing, resulting in a pipeline of hematology and ophthalmology programs.
Emendo Biotherapeutics develops gene editing platform to expand the list of diseases amenable to treatment with gene editing, resulting in a pipeline of hematology and ophthalmology programs.
9
Country: USA | Funding: $318M
Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients (including with Thyroid Eye Disease ).
Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients (including with Thyroid Eye Disease ).
10
Country: UK | Funding: $290.1M
Beacon Therapeutics is an ophthalmic gene therapy company to treat blinding retinal illnesses and restore and enhance eyesight.
Beacon Therapeutics is an ophthalmic gene therapy company to treat blinding retinal illnesses and restore and enhance eyesight.
